Bank of New York Mellon’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$635K Buy
28,081
+7,412
+36% +$166K ﹤0.01% 3626
2026
Q1
$466K Sell
20,669
-276
-1% -$6.34K ﹤0.01% 3645
2025
Q4
$499K Sell
20,945
-505
-2% -$12.6K ﹤0.01% 3616
2025
Q3
$565K Sell
21,450
-117
-0.5% -$3.01K ﹤0.01% 3520
2025
Q2
$616K Sell
21,567
-504
-2% -$13.5K ﹤0.01% 3396
2025
Q1
$550K Buy
22,071
+120
+0.5% +$2.86K ﹤0.01% 3398
2024
Q4
$497K Buy
21,951
+1,205
+6% +$26.2K ﹤0.01% 3529
2024
Q3
$442K Buy
20,746
+3,939
+23% +$77.5K ﹤0.01% 3588
2024
Q2
$321K Sell
16,807
-585
-3% -$11.9K ﹤0.01% 3788
2024
Q1
$335K Buy
17,392
+2,840
+20% +$56.3K ﹤0.01% 3732
2023
Q4
$303K Sell
14,552
-8,819
-38% -$169K ﹤0.01% 3795
2023
Q3
$503K Sell
23,371
-873
-4% -$21.2K ﹤0.01% 3539
2023
Q2
$580K Buy
24,244
+4,042
+20% +$92.7K ﹤0.01% 3505
2023
Q1
$429K Buy
20,202
+2,846
+16% +$54.5K ﹤0.01% 3562
2022
Q4
$284K Buy
17,356
+6,799
+64% +$101K ﹤0.01% 3819
2022
Q3
$148K Sell
10,557
-14,569
-58% -$275K ﹤0.01% 4120
2022
Q2
$626K Sell
25,126
-2,911
-10% -$87K ﹤0.01% 3454
2022
Q1
$945K Buy
28,037
+4,162
+17% +$137K ﹤0.01% 3354
2021
Q4
$774K Sell
23,875
-2,114
-8% -$69.6K ﹤0.01% 3531
2021
Q3
$909K Buy
25,989
+2,252
+9% +$88K ﹤0.01% 3443
2021
Q2
$987K Sell
23,737
-850
-3% -$34K ﹤0.01% 3429
2021
Q1
$908K Sell
24,587
-101,058
-80% -$3.82M ﹤0.01% 3386
2020
Q4
$5.22M Sell
125,645
-45,343
-27% -$1.89M ﹤0.01% 2340
2020
Q3
$7.26M Sell
170,988
-4,953
-3% -$214K ﹤0.01% 2026
2020
Q2
$7.62M Buy
175,941
+154,476
+720% +$6.1M ﹤0.01% 1984
2020
Q1
$704K Buy
+21,465
New +$798K ﹤0.01% 3201
2019
Q4
Sell
-7,702
Closed -$259K 4205
2019
Q3
$259K Sell
7,702
-2,045
-21% -$72.5K ﹤0.01% 3825
2019
Q2
$382K Sell
9,747
-4,213
-30% -$167K ﹤0.01% 3725
2019
Q1
$565K Sell
13,960
-3,271
-19% -$122K ﹤0.01% 3495
2018
Q4
$559K Sell
17,231
-3,294
-16% -$133K ﹤0.01% 3430
2018
Q3
$1.06M Sell
20,525
-8,536
-29% -$427K ﹤0.01% 3229
2018
Q2
$1.46M Buy
29,061
+1,731
+6% +$87.8K ﹤0.01% 3027
2018
Q1
$1.4M Sell
27,330
-5,735
-17% -$306K ﹤0.01% 3024
2017
Q4
$1.74M Sell
33,065
-20,198
-38% -$1M ﹤0.01% 2924
2017
Q3
$2.6M Buy
53,263
+2,429
+5% +$115K ﹤0.01% 2687
2017
Q2
$2.46M Buy
50,834
+1,584
+3% +$73K ﹤0.01% 2727
2017
Q1
$2.08M Buy
49,250
+10,751
+28% +$444K ﹤0.01% 2831
2016
Q4
$1.63M Buy
38,499
+6,993
+22% +$285K ﹤0.01% 2976
2016
Q3
$1.38M Sell
31,506
-10,774
-25% -$482K ﹤0.01% 2995
2016
Q2
$1.84M Buy
42,280
+2,838
+7% +$122K ﹤0.01% 2758
2016
Q1
$1.74M Sell
39,442
-532
-1% -$22.5K ﹤0.01% 2736
2015
Q4
$1.67M Buy
39,974
+747
+2% +$31.5K ﹤0.01% 2825
2015
Q3
$1.53M Buy
39,227
+14,427
+58% +$587K ﹤0.01% 2902
2015
Q2
$1.03M Buy
24,800
+1,983
+9% +$84.7K ﹤0.01% 3318
2015
Q1
$946K Sell
22,817
-8,292
-27% -$320K ﹤0.01% 3337
2014
Q4
$1.15M Buy
31,109
+1,001
+3% +$36.1K ﹤0.01% 3223
2014
Q3
$1.04M Sell
30,108
-31,703
-51% -$1.09M ﹤0.01% 3256
2014
Q2
$2.07M Sell
61,811
-57,450
-48% -$1.92M ﹤0.01% 2885
2014
Q1
$4.16M Sell
119,261
-103,614
-46% -$3.63M ﹤0.01% 2421
2013
Q4
$7.93M Buy
222,875
+3,537
+2% +$119K ﹤0.01% 2008
2013
Q3
$7.1M Sell
219,338
-46,092
-17% -$1.5M ﹤0.01% 2017
2013
Q2
$9.36M Buy
+265,430
New +$9.23M ﹤0.01% 1820

Other funds holding FMS

Bank of New York Mellon's FMS Position: Q2 2026 in Review

Bank of New York Mellon increased its Fresenius Medical Care (FMS) stake by 36% in Q2 2026, buying an estimated $166K and bringing the position to 28,081 shares worth $635K. The position accounts for ﹤0.01% of the portfolio, ranked #3626.

Bank of New York Mellon first reported a position in FMS in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.36M in Q2 2013. 115 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Bank of New York Mellon held 28,081 shares of Fresenius Medical Care worth $635K as of Q2 2026.
  • Bank of New York Mellon bought 7,412 Fresenius Medical Care shares in Q2 2026, an estimated $166K.
  • Fresenius Medical Care made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3626 holding.
  • Bank of New York Mellon first reported a position in Fresenius Medical Care in Q2 2013 and has held it in 52 quarters since.
  • Bank of New York Mellon's Fresenius Medical Care position peaked at $9.36M in Q2 2013.
  • 115 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.